Armistice Capital’s Dermata Therapeutics DRMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $188K | Sell |
32,218
-8,882
| -22% | -$52K | ﹤0.01% | 177 |
|
|
2025
Q1 | $444K | Buy |
41,100
+38,380
| +1,411% | +$415K | 0.01% | 178 |
|
|
2024
Q4 | $36.7K | Buy |
+2,720
| New | +$36.7K | ﹤0.01% | 207 |
|
|
2024
Q3 | – | Sell |
-2,800
| Closed | -$66.9K | – | 274 |
|
|
2024
Q2 | $66.9K | Buy |
+2,800
| New | +$66.9K | ﹤0.01% | 229 |
|
|
2024
Q1 | – | Sell |
-1,453
| Closed | -$133K | – | 355 |
|
|
2023
Q4 | $133K | Buy |
+1,453
| New | +$133K | ﹤0.01% | 248 |
|
|
2022
Q3 | – | Sell |
-265
| Closed | -$414 | – | 209 |
|
|
2022
Q2 | $414 | Buy |
+265
| New | +$414 | 0.01% | 139 |
|